The G1, S, G2, and M phases are the four stages every dividing cell passes through in a repeating loop called the cell cycle. G1 is a growth period where the cell prepares to copy its DNA. S is the phase where that DNA actually gets duplicated. G2 is a second growth period where the cell checks its work and gears up for division. M is mitosis, when the cell physically separates its duplicated chromosomes and splits in two. The whole process is tightly controlled by internal checkpoints and molecular signals, and when that control breaks down, the consequences range from cell death to cancer.
G1, the First Growth Phase
After a cell is born from a previous division, it enters G1 (short for “gap 1”). This is the longest and most variable phase for most cell types. During G1, the cell is metabolically active: it grows in size, produces proteins, and builds the organelles it will need. But the real significance of G1 is that it serves as the cell’s decision-making window. Signals from the environment, including nutrients, growth factors, and contact with neighboring cells, all feed into the question of whether the cell should commit to dividing again or step out of the cycle entirely.
The critical moment in G1 is called the restriction point. Before reaching it, the cell’s decision to proceed is still reversible; if growth signals disappear, the cell can pause or exit. Once it passes the restriction point, though, the cell is committed to entering S phase and completing division regardless of whether those external signals continue. The restriction point is controlled largely by the retinoblastoma protein (pRb), which acts as a brake on gene activity needed for DNA replication. When the right combination of growth signals arrives, enzymes called cyclin-dependent kinases disable pRb by adding phosphate groups to it, releasing that brake and allowing the cell to move forward.1PubMed. The retinoblastoma protein pathway and the restriction point This molecular gate is why G1 is sometimes described as the phase where the cell “decides” to divide.
S Phase and DNA Replication
S phase (for “synthesis”) is when the cell copies its entire genome. Every chromosome gets duplicated so that the eventual daughter cells each receive a complete set of genetic instructions. This is a massive undertaking: in a human cell, roughly six billion base pairs of DNA need to be faithfully replicated. The copying process begins at thousands of specific sites along the chromosomes called origins of replication, which fire in a coordinated sequence rather than all at once.
DNA replication requires more than just copying the genetic sequence. The freshly made DNA has to be packaged with histone proteins to form proper chromatin structure, and this packaging is tightly linked to how fast the replication machinery can move. Research has shown that the availability of newly synthesized histones is essential for replication fork progression, and that disrupting histone production can act as a brake on DNA copying even when the replication machinery itself is functional.2The FASEB Journal. Coupling arginine with DNA replication and chemoresistance S phase also includes an active error-checking system: mismatch repair enzymes trail behind the replication machinery, catching and fixing mistakes in the newly copied DNA. Errors that slip through here can become permanent mutations.
G2, the Final Preparation
G2 (gap 2) sits between the completion of DNA replication and the start of mitosis. It tends to be shorter than G1, but it serves a distinct purpose. The cell continues to grow and synthesize proteins, particularly those needed for division, such as tubulin, which will form the structural scaffolding of the mitotic spindle. G2 is also when the cell runs a damage check on its freshly replicated DNA. If unrepairable breaks or other serious errors are detected, checkpoint machinery halts the cycle to prevent the cell from entering mitosis with a damaged genome.
The DNA damage checkpoint active in G2 relies on sensor proteins that detect structural problems in chromosomes and relay that information to downstream signaling pathways. When the checkpoint detects damage, it blocks the activation of the enzyme complex that would trigger mitosis, effectively keeping the cell in G2 until repairs are made. If the damage is too severe to fix, the checkpoint can redirect the cell toward programmed death rather than allowing it to divide with corrupted DNA.
M Phase and the Division Itself
M phase is mitosis, the stage where the cell actually divides. It unfolds in a series of rapid, visually dramatic substages. First, during prophase, the duplicated chromosomes condense into compact, visible structures. The nuclear envelope begins to break down, and a structure called the mitotic spindle starts to form from opposite sides of the cell. During prometaphase, spindle fibers attach to each chromosome at a specialized structure called the kinetochore. In metaphase, all the chromosomes line up along the cell’s equator. Then, in anaphase, the sister chromatids are pulled apart to opposite poles. Finally, during telophase, new nuclear envelopes form around each set of chromosomes, and the chromatin begins to decondense.
The accuracy of chromosome separation during M phase depends on a quality-control system called the spindle assembly checkpoint. This checkpoint monitors whether every chromosome is properly attached to spindle fibers from both poles of the cell before allowing the cell to proceed to anaphase. Specifically, it works by assembling a protein complex that blocks the signal for sister chromatid separation until all kinetochore-microtubule attachments are correct.3PubMed Central. Regulation of mitotic progression by the spindle assembly checkpoint Even a single unattached chromosome is enough to keep the checkpoint engaged and delay the entire process.4PubMed Central. Phosphorylation regulates the p31Comet-mitotic arrest-deficient 2 (Mad2) interaction to promote spindle assembly checkpoint (SAC) activity If the checkpoint fails, daughter cells can end up with the wrong number of chromosomes, a condition called aneuploidy, which is a hallmark of many cancers.
Cytokinesis, the Step After M Phase
Mitosis separates the chromosomes, but the cell is not yet two cells. That final physical split is called cytokinesis, which overlaps with the end of M phase but is technically a distinct event. In animal cells, a ring of contractile protein fibers tightens around the cell’s midsection like a drawstring, pinching the cell into two. In plant cells, the mechanism is fundamentally different: a new cell wall is built outward from the center of the cell toward its edges, creating a partition between the two daughters.5PubMed Central. Cytokinesis in eukaryotes The outcome is the same: two genetically identical cells, each now in G1 and ready to begin the cycle again (or to exit it).
Cytokinesis can occasionally fail, producing a single cell with two nuclei and a double set of chromosomes. This is not always catastrophic; some tissues tolerate or even use binucleate cells. But in most contexts, cytokinesis failure triggers additional checkpoint mechanisms that push the cell into arrest or death, because a cell with too many chromosomes can be dangerous if it keeps dividing.
G0, the Exit Ramp
Not every cell keeps cycling. Many cells in your body exit the cycle entirely and enter a resting state called G0. Neurons, most muscle cells, and fully differentiated cells of many tissues sit in G0 for years or even a lifetime. G0 is not a dead end in every case, though. Some cells, like liver cells, normally sit quietly in G0 but can re-enter the cycle if the tissue is damaged and needs repair. Others, like neurons, are essentially locked in G0 permanently.
Within G0 itself, there is an important distinction between quiescence and senescence. Quiescent cells are resting but can, in principle, be coaxed back into dividing. Senescent cells have permanently stopped dividing, often in response to accumulated damage or shortening of their chromosome tips (telomeres). Researchers have found that quiescent cells differ from senescent cells at the molecular level: senescent cells maintain active protein synthesis, while truly quiescent cells scale that down.6PubMed Central. Different Stages of Quiescence, Senescence, and Cell Stress Identified by Molecular Algorithm Based on the Expression of Ki67, RPS6, and Beta-Galactosidase Activity This distinction matters medically because senescent cells that accumulate in tissues are now thought to contribute to aging and age-related disease.
What Drives the Cycle Forward
The cell cycle is not a simple timer that ticks from one phase to the next. Its progression depends on a family of enzymes called cyclin-dependent kinases (CDKs). These enzymes are only active when bound to partner proteins called cyclins, and different cyclin-CDK pairs are active in different phases. The concentrations of cyclins rise and fall in a predictable wave pattern across the cycle: one set peaks in G1, another in S, another in G2/M. When the right cyclin reaches a threshold level, it activates its CDK partner, which then phosphorylates downstream targets to push the cell into the next phase.7PubMed Central. The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
This system has built-in checks. CDK inhibitor proteins can block cyclin-CDK activity, giving the cell a way to hit the brakes if conditions are not right. The DNA damage checkpoints in G1, S, and G2 all work, at least in part, by ramping up CDK inhibitors or blocking cyclin accumulation. The result is a system that can both drive division forward and halt it at multiple stages when something goes wrong.
How Nutrients and Metabolism Influence the Cycle
The cell cycle is often described purely in terms of genes and proteins, but metabolism plays a direct role in whether a cell divides. Growth requires raw materials: amino acids, nucleotides, lipids, and energy. If those resources are scarce, the cell will stall in G1 rather than committing to the costly process of DNA replication and division. This connection runs in both directions: metabolic pathways influence cell cycle proteins directly, and the cell cycle, in turn, reshapes the cell’s metabolic priorities as it progresses through different phases.8PubMed. The bidirectional relationship between metabolism and cell cycle control
For example, during S phase, the cell needs to dramatically increase its production of nucleotides to supply the DNA replication machinery. During G2 and early M, it shifts toward building the structural proteins needed for the mitotic spindle. Nutrient-sensing signaling pathways, many of which are the same pathways that respond to insulin and growth factors, integrate information about the cell’s metabolic state and feed it into the cyclin-CDK machinery. When you fast for an extended period or when a tumor outgrows its blood supply and becomes nutrient-starved, it is this metabolic sensing that stalls cell cycle progression.
When the Cell Cycle Goes Wrong
Cancer, at its core, is a disease of uncontrolled cell division. Nearly every cancer involves some disruption of the cell cycle’s normal regulatory machinery. Mutations in the genes encoding cyclins, CDKs, CDK inhibitors, or checkpoint proteins can allow cells to blow through the restriction point or divide despite DNA damage. The pRb pathway, for instance, is inactivated in a wide range of tumor types, which effectively removes the G1 brake and lets cells divide without waiting for appropriate growth signals.
This understanding has led directly to cancer drugs that target the cell cycle. A class of drugs called CDK4/6 inhibitors works by blocking the specific kinases that phosphorylate pRb in G1, effectively forcing cancer cells back into arrest. These drugs have been approved for metastatic hormone receptor-positive breast cancer and are in clinical trials for many other tumor types.9PubMed Central. CDK4 and CDK6 kinases: From basic science to cancer therapy Beyond simply halting division, CDK4/6 inhibitors also appear to alter cancer cell biology in other ways that may prove therapeutically useful, including effects on the immune response to tumors.10PubMed Central. CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest The broader family of CDK inhibitors continues to expand, with ongoing work targeting different CDKs for different cancer types.11PubMed Central. CDK inhibitors in cancer therapy, an overview of recent development
Not All Cells Follow the Textbook Cycle
The four-phase cycle described above is the standard model, but biology is full of variations. Some cells skip phases entirely. In early embryonic development, for instance, the first several rounds of cell division are dramatically simplified: the fertilized egg divides rapidly through alternating S and M phases with essentially no G1 or G2 gaps. These fast cleavage divisions rely on stockpiles of proteins and mRNA provided by the mother’s egg, so the cells do not need the growth phases that adult cells require.12PubMed Central. Cell cycle control during early embryogenesis As development proceeds, gap phases are gradually introduced and checkpoints come online.
Another variation is endoreplication, where a cell copies its DNA without dividing at all. The cell enters S phase, duplicates its genome, but then skips M phase entirely and returns to G1 with double the DNA content. Repeating this process produces polyploid cells with many copies of each chromosome. This is not always abnormal: some tissues rely on it. Liver cells in mammals are frequently polyploid, and certain insect and plant cells use endoreplication as a normal growth strategy. Polyploidy also shows up in disease, particularly cancer, where cells with abnormal chromosome numbers often arise through failed or incomplete division.13PubMed Central. Endoreplication and polyploidy: insights into development and disease
How Researchers Watch Cells Move Through the Cycle
Much of what we know about the cell cycle comes from being able to watch individual cells progress through it. For decades, the primary tool was flow cytometry, which measures the amount of DNA in each cell in a population and sorts them into rough phase categories (cells in G1 have a baseline amount of DNA, cells in S have an intermediate amount as they replicate, and cells in G2/M have double). But this method only gives a snapshot and cannot follow a single cell over time.
A more recent tool called FUCCI (Fluorescent Ubiquitination-based Cell Cycle Indicator) solved that problem by engineering cells to glow different colors depending on which phase they are in. Cells in G1 glow red-orange, while cells in S/G2/M glow green, based on fluorescent proteins that are tagged for destruction at specific cell cycle transitions. Researchers can combine FUCCI with flow cytometry to sort living cells by phase and then study each population separately.14PubMed Central. Expanding the utility of FUCCI reporters using FACS-based ‘omics analysis This approach has proven especially useful for studying how anticancer drugs affect cell cycle progression. When researchers treated FUCCI-labeled cells with different chemotherapy agents, they found striking diversity in how each drug altered the cycle: some caused arrest in one specific phase, others caused cells to skip phases or fuse abnormally.15PubMed Central. Drug-induced cell cycle modulation leading to cell-cycle arrest, nuclear mis-segregation, or endoreplication Tools like FUCCI have moved the field from studying cell cycle regulation in populations to tracking it in real time at the single-cell level, revealing variability that population-average methods had been hiding for decades.